Lately, Siemens Healthineers, Siemens’ healthcare division, has invested Rs 200 million to integrate R&D and manufacturing in a manufacturing facility in Bengaluru. While there are certainly business gains, the company is heading to have Artificial Intelligence (AI) as one of the main pillars of technology in its products. This strives to be pragmatic in its commitment to integrating AI into its services as a market leader. It says AI is going to pan out in stages, with first hybrid devices coming to market. It’s about bringing AI into every surgery/treatment operation in the grand scheme of things. Presently, in cardiology, AI is used to predict the intensity of scar tissues that are induced to treat atrial fibrillation/arrhythmia during ablation operations. This requires a well-trained AI system that can take into account in real-time the different aspects of arrhythmia anatomy and severity. New business models and problems are moving together with new tech. When the computers developed and installed in India start to interact with a global network, information becomes this communication’s currency. “We have a 6,00,000 equipment base installed around the world. Thinking that the data gathered from these can be fed into an AI program is not right. We require permission from the hospitals that own these facilities even to begin research activities, “Seitz, executive vice president – surgery, Siemens Healthineers, says. AI would enable information to be managed and protected by the computers. The data will enable hospitals to rethink their revenue channels. The Bengaluru center also has the duty to train software engineers and houses 1900 R&D employees. It has created an imaging platform called Syngo that can build life-like images of human anatomy in high resolution and has over 2,00,000 deployments worldwide.